EMA receives application for CMA of Remdesivir for treatment of COVID-19 The assessment of benefits, risks of Remdesivir is being performed under reduced timeline, opinion could be issued within weeks,…
NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19 The trial sponsored by NIAID, part of the National Institutes of Health, is the first clinical trial launched in the US…
Jubilant Life Sciences – Q4, FY20 results EBITDA was at Rs 1,555 Crore, up 13 per cent YoY with margin at 27.2 per cent, as compared with 25.7 per cent in FY19
CSIR-IICT collaborates with Carbanio.com Carbanio is working closely with IICT to ensure that their requirements are met during this crucial time